This article first appeared on GuruFocus .
-
Revenue:$2.5 million in Q2 2026, consisting of $2.5 million in staking revenue and $14,000 in other revenue, compared with $43,000 in Q2 2025.
-
Gross Margin:Approximately 97% in Q2 2026, with gross profit of $2.4 million.
-
Net Loss:$13.3 million, or $0.38 per basic and diluted share, for Q2 2026.
-
General and Administrative Expenses:$11.1 million in Q2 2026, including $6.8 million in non-recurring severance costs related to the Pons divestiture.
-
Digital Asset Fair Value Movements:Unrealized gain of $2.4 million and realized loss of $25.4 million in Q2 2026.
-
Staking Yield:Average net staking yield of 6.14% APY in Q2 2026, outperforming the network average of 5.68% by 46 basis points.
-
SOL Holdings:Approximately 2.3 million SOL held as of June 30, 2026, with a fair value of approximately $170.6 million.
-
Share Repurchases:Repurchased 1.3 million shares for approximately $2.3 million in Q2 2026.
-
Cash and Cash Equivalents:$3.6 million as of June 30, 2026.
-
Total Assets:$176.1 million as of June 30, 2026.
Release Date: August 14, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Solana Co ( NASDAQ:HSDT ) successfully launched its first institutional validated cluster in Tokyo, securing its first third-party stake commitment of approximately $0.5 million, which is expected to generate revenue in Q3 2026.
-
The company divested its cash-consuming medical device business and acquired a profitable Hong Kong-regulated trust company, enhancing its financial focus and operational capabilities.
-
Staking rewards contributed $2.5 million in Q2 2026, with a net staking yield of 6.14% APY, outperforming the Solana network average by 46 basis points.
-
Solana Co ( NASDAQ:HSDT ) executed $2.3 million in share repurchases during the quarter, retiring 1.3 million shares, and improved its MNAV from 0.73 to 0.81 times, demonstrating disciplined capital allocation.
-
The company formed strategic partnerships with the JITO Foundation and Alatal City, expanding its institutional infrastructure and policy-level engagement in Asia Pacific.
-
Advisory services delivered 15 institutional education sessions and workshops, building a pipeline that is converting into negotiations for third-party engagements.
Negative Points
-
Solana Co ( NASDAQ:HSDT ) reported a net loss of $13.3 million for Q2 2026, with significant non-cash fair value losses on digital assets, including a $25.4 million realized loss from strategic sales.
-
General and administrative expenses increased significantly to $11.1 million in Q2 2026, up from $3.3 million in the prior year, partly due to $6.8 million in severance costs.
-
The company's SOL holdings declined approximately 12% during the quarter, following a 33% decline in Q1, reflecting ongoing market volatility and price pressure.
-
The validated infrastructure business is still in early stages, with only one cluster operational and limited third-party stake, indicating a slow ramp-up to meaningful revenue contribution.
-
The company's stock continues to trade at a discount to net asset value (0.81 times), limiting the ability to issue shares accretively and relying on buybacks, which may not fully offset dilution from warrants.
-
The acquisition of the Hong Kong trust company and other strategic initiatives involve integration risks and may not immediately generate expected synergies or revenue.
Q & A Highlights
Q: Regarding Pacific Backbone monetization, what is the revenue model once the Jito market layer tech is integrated, and what is the realistic timeline for this project to move from a cost center to a revenue contributor? A: Joseph Chee (Executive Chairman): This is no different from other validators with Jito as a partner. We are optimizing performance to get slightly above average versus the market. This is not a cost center; we already secured third-party SOL into it and expect revenue to come through. We expect it to be profitable this year, and we continue to win more third-party SOL to stake at the cluster, with new validator nodes launching in the coming quarters.
Q: Can you frame what we should expect from a capital allocation perspective in Q3 and Q4 for the balance of the year? A: Cosmo Jiang (Director): We will keep to the plan of maximizing Solana per share accretion daily. When trading at a discount to NAV, we are happy to buy back stock, which is accretive on a SOL-per-share basis. On the flip side, there is tremendous strategic interest from large Asia-Pacific corporates, and we can create value by engaging with them on a staking or capital basis, as evidenced by bringing on Mirae Asset in an accretive transaction. As markets rebound, we expect capital market activity to rebound with it.
Q: As you begin generating material cash flow from operating businesses, how do you think about allocating that capital between buybacks and reinvesting in the operating business? A: Cosmo Jiang (Director): We take a total allocation approach regardless of where revenue comes from. We will first pay for expenses required to keep the business growing. If the highest and best use of capital is buybacks because of where we are trading, we will do that; if it is buying Solana because we are trading at a premium, we will do that. The end goal is always maximizing Solana per share.
Q: Given the market is in a consolidation phase and other SOL treasuries trade at deeper discounts, do you see yourself as a consolidator of existing digital asset treasuries as an attractive path to creating SOL per share? A: Cosmo Jiang (Director): The space is small and we all know each other. Finding the right circumstances from a timing and management synergy perspective requires a lot of work. The opportunity for accretion is absolutely there, and we are happy to do anything that maximizes shareholder value on either side of the coin.
Q: What is the expected revenue impact from the validator business in Q3 on top of what you have now? A: Joseph Chee (Executive Chairman): We do not have the numbers available to give a forecast at this time. We do expect revenue to come through and are trying to build more SOL into the validator. At the right time, we will be able to provide guidance.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
